{
    "clinical_study": {
        "@rank": "162995", 
        "arm_group": [
            {
                "arm_group_label": "control group", 
                "arm_group_type": "Other", 
                "description": "healthy volunteer"
            }, 
            {
                "arm_group_label": "obesity group", 
                "arm_group_type": "Other", 
                "description": "Patients with BMI >30 Kg/m2"
            }, 
            {
                "arm_group_label": "white coat hypertension group", 
                "arm_group_type": "Other", 
                "description": "Patients with office blood pressure >140/90 mmHg and ambulatory daytime blood pressure <135/85 mmHg"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether in pre-hypertensive states such as white\n      coat hypertension or obesity related hypertension, renal function is more sensitive to\n      orthostatic stress."
        }, 
        "brief_title": "Renal Response to Lower Body Negative Pressure in Pre-hypertensive States", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hypertension", 
            "Obesity", 
            "White Coat Hypertension"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypertension", 
                "Obesity"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  BMI > 30 Kg/m2 (obesity group)\n\n          -  office BP >140/90 and daytime ambulatory blood pressure <135/85 (white coat\n             hypertension group)\n\n        Exclusion Criteria:\n\n          -  History of allergic reaction\n\n          -  Diabetes type 1 or type 2\n\n          -  History of renal artery stenosis\n\n          -  Acute illness"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 21, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01734096", 
            "org_study_id": "PZ00P3_121655"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "control group", 
                    "obesity group", 
                    "white coat hypertension group"
                ], 
                "description": "Lower limbs are put in in LBNP device for one hour (-30 mbar)", 
                "intervention_name": "Lower body negative pressure (LBNP)", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "control group", 
                    "obesity group", 
                    "white coat hypertension group"
                ], 
                "description": "candesartan cilexetil 16 mg once a day for 7 days cross over with placebo", 
                "intervention_name": "Candesartan cilexetil", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Candesartan cilexetil", 
                "Candesartan"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "hypertension", 
            "obesity", 
            "white coat hypertension"
        ], 
        "lastchanged_date": "July 10, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Lausanne", 
                        "country": "Switzerland", 
                        "state": "VD", 
                        "zip": "1011"
                    }, 
                    "name": "Service of nephrology and hypertension"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lausanne", 
                        "country": "Switzerland", 
                        "zip": "1011"
                    }, 
                    "name": "Service of nephrology and hypertension"
                }
            }
        ], 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "3", 
        "official_title": "Effect of Lower Body Negative Pressure and Angiotensin II Receptor Blockade on Renal Hemodynamic, Neuro-hormonal and Tubular Response in Pre-hypertensive States: a Randomized Controlled Trial.", 
        "other_outcome": {
            "measure": "renal plasma flow", 
            "safety_issue": "No", 
            "time_frame": "after one hour of lower body negative pressure"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "sodium excretion will be compared to control group (healthy volunteers) after one hour of lower negative pressure. The protocol includes 2 hours of baseline measure, one hour of lower negative pressure and 2 hours of recovery", 
            "measure": "sodium excretion", 
            "safety_issue": "No", 
            "time_frame": "after one hour of lower body negative pressure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01734096"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centre Hospitalier Universitaire Vaudois", 
            "investigator_full_name": "PD Dr. Gr\u00e9goire Wuerzner", 
            "investigator_title": "Doctord, MD, privat docent", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "glomerular filtration rate", 
            "safety_issue": "No", 
            "time_frame": "after one hour of lower body negative pressure"
        }, 
        "source": "Centre Hospitalier Universitaire Vaudois", 
        "sponsors": {
            "collaborator": {
                "agency": "Swiss National Science Foundation", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "PD Dr. Gr\u00e9goire Wuerzner", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}